Stanford University

Showing 511-520 of 840 Results

• Claudia Bobadilla

  Casual Employee, Medicine - Med/Stanford Prevention Research Center
  
• Robert Charles Bocian

  Adjunct Clinical Associate Professor, Pediatrics - Immunology
  
• Rudolf H. Bock

  Emeritus Adjunct Clinical Assistant Professor, Ophthalmology
  
• 

  Irene Gonzalez Bockenkamp

  Adm Assoc 3, Stem Cell Bio Regenerative Med Institute
  
• Sandhya Bodapati

  Affiliate, Department Funds
  Resident in Radiology
  
• 

  Mark Boddy

  Clinical Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
  
• Steven Bodine

  Postdoctoral Scholar, Chemistry
  

  • Contact Info

    Mail Code: 5080

    spbodine@stanford.edu
• 

  Anu Bodla

  Affiliate, Department Funds
  Fellow in Psychiatry and Behavioral Sciences
  
• Natalie Bodmer

  Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
  
• 

  Christina Bodurow

  Affiliate, Medicine - Med/Gastroenterology and Hepatology
  

  BioChris has a proven record of accomplishment delivering results to pharmaceutical and scientific organizations, including 33 years of management experience at Eli Lilly and Company, within Lilly Research Laboratories (LRL), 3.5 years in a global leadership role at IQVIA, and now as Deputy Director and COO of a significant NIH/NIAID research grant at Stanford University Medical School.
  
  Over the years, Chris has served as a leader of multiple global teams in drug development and R&D Operations, representing her organizations in multiple external settings, including scientific, academic, drug development and R&D Operations forums.
  
  In, December 2017, Chris retired from Lilly as Sr. Director, External Sourcing, leading an enterprise-wide R&D operations group that partnered with LRL functions to assess, on-board, and govern third party organizations across the entire drug development value chain, from pre-clinical, through clinical, regulatory, safety, health outcomes, product and device development, and diagnostics. The division consolidated both corporate and external requirements to deliver high-quality, risk-based, third party governance, oversight and alliance management for the LRL Development organization.
  
  In February 2019, Chris joined IQVIA as the Vice-President of Strategy & Operations for DSSR, and subsequently moved in the role of Vice-President, Global Regulatory Affairs.
  
  Specialties: Pharmaceutical Development, R&D Operations, Molecule Submission/Approval/Launch, Product Lifecycle Planning and Development, R&D Business Systems design and delivery. Third Party Management, Women's Leadership Development.